Report Detail

Other Global Gene Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM2952633
  • |
  • 27 August, 2019
  • |
  • Global
  • |
  • 103 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy。

Scope of the Report:
Today, Gene Therapy is used for Cancer Diseases, Hematological Disease and Hereditary Disease. Cancer Diseases is the largest application of Gene Therapy and its market share exceed 78% in 2018.
The global Gene Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gene Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Kite Pharma
BioVex
Novartis
Spark Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Ex Vivo
In Vivo

Market Segment by Applications, can be divided into
Cancer Diseases
Hematological Disease
Hereditary Disease
Others


Table of Contents

    1 Gene Therapy Market Overview

    • 1.1 Product Overview and Scope of Gene Therapy
    • 1.2 Classification of Gene Therapy by Types
      • 1.2.1 Global Gene Therapy Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Gene Therapy Revenue Market Share by Types in 2018
      • 1.2.3 Ex Vivo
      • 1.2.4 In Vivo
    • 1.3 Global Gene Therapy Market by Application
      • 1.3.1 Global Gene Therapy Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Cancer Diseases
      • 1.3.3 Hematological Disease
      • 1.3.4 Hereditary Disease
      • 1.3.5 Others
    • 1.4 Global Gene Therapy Market by Regions
      • 1.4.1 Global Gene Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Gene Therapy Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Gene Therapy (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Kite Pharma
      • 2.1.1 Business Overview
      • 2.1.2 Gene Therapy Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Kite Pharma Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 BioVex
      • 2.2.1 Business Overview
      • 2.2.2 Gene Therapy Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 BioVex Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Gene Therapy Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Spark Therapeutics
      • 2.4.1 Business Overview
      • 2.4.2 Gene Therapy Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Gene Therapy Market Competition, by Players

    • 3.1 Global Gene Therapy Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Gene Therapy Players Market Share
      • 3.2.2 Top 10 Gene Therapy Players Market Share
    • 3.3 Market Competition Trend

    4 Global Gene Therapy Market Size by Regions

    • 4.1 Global Gene Therapy Revenue and Market Share by Regions
    • 4.2 North America Gene Therapy Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Gene Therapy Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Gene Therapy Revenue and Growth Rate (2014-2019)
    • 4.5 South America Gene Therapy Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Gene Therapy Revenue and Growth Rate (2014-2019)

    5 North America Gene Therapy Revenue by Countries

    • 5.1 North America Gene Therapy Revenue by Countries (2014-2019)
    • 5.2 USA Gene Therapy Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Gene Therapy Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Gene Therapy Revenue and Growth Rate (2014-2019)

    6 Europe Gene Therapy Revenue by Countries

    • 6.1 Europe Gene Therapy Revenue by Countries (2014-2019)
    • 6.2 Germany Gene Therapy Revenue and Growth Rate (2014-2019)
    • 6.3 UK Gene Therapy Revenue and Growth Rate (2014-2019)
    • 6.4 France Gene Therapy Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Gene Therapy Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Gene Therapy Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Gene Therapy Revenue by Countries

    • 7.1 Asia-Pacific Gene Therapy Revenue by Countries (2014-2019)
    • 7.2 China Gene Therapy Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Gene Therapy Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Gene Therapy Revenue and Growth Rate (2014-2019)
    • 7.5 India Gene Therapy Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Gene Therapy Revenue and Growth Rate (2014-2019)

    8 South America Gene Therapy Revenue by Countries

    • 8.1 South America Gene Therapy Revenue by Countries (2014-2019)
    • 8.2 Brazil Gene Therapy Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Gene Therapy Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Gene Therapy Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Gene Therapy by Countries

    • 9.1 Middle East and Africa Gene Therapy Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Gene Therapy Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Gene Therapy Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Gene Therapy Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Gene Therapy Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Gene Therapy Revenue and Growth Rate (2014-2019)

    10 Global Gene Therapy Market Segment by Type

    • 10.1 Global Gene Therapy Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Gene Therapy Market Forecast by Type (2019-2024)
    • 10.3 Ex Vivo Revenue Growth Rate (2014-2024)
    • 10.4 In Vivo Revenue Growth Rate (2014-2024)

    11 Global Gene Therapy Market Segment by Application

    • 11.1 Global Gene Therapy Revenue Market Share by Application (2014-2019)
    • 11.2 Gene Therapy Market Forecast by Application (2019-2024)
    • 11.3 Cancer Diseases Revenue Growth (2014-2019)
    • 11.4 Hematological Disease Revenue Growth (2014-2019)
    • 11.5 Hereditary Disease Revenue Growth (2014-2019)
    • 11.6 Others Revenue Growth (2014-2019)

    12 Global Gene Therapy Market Size Forecast (2019-2024)

    • 12.1 Global Gene Therapy Market Size Forecast (2019-2024)
    • 12.2 Global Gene Therapy Market Forecast by Regions (2019-2024)
    • 12.3 North America Gene Therapy Revenue Market Forecast (2019-2024)
    • 12.4 Europe Gene Therapy Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Gene Therapy Revenue Market Forecast (2019-2024)
    • 12.6 South America Gene Therapy Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Gene Therapy Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Gene Therapy . Industry analysis & Market Report on Gene Therapy is a syndicated market report, published as Global Gene Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,756.16
      4,134.24
      5,512.32
      3,222.48
      4,833.72
      6,444.96
      526,698.00
      790,047.00
      1,053,396.00
      290,232.00
      435,348.00
      580,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report